GEMValue Tuberculosis Data File Share

This data set contains the listings of 40 essential medicines used to manage Tuberculosis (TB) across 137 countries' national essential medicines lists (NEMLs). These medicines were identified from The World Health Organization (WHO) Model List of Essential Medicines (20th edition) and selected WHO treatment guidelines for TB (2014 through 2019). NEMLs were obtained from our Global Essential Medicines database1. Medicines listed on NEMLs are indicated by a "1" and those not listed by a "0". Also included are selected country characteristics: WHO designated high-burden multi-drug resistant TB states and WHO Region, 2016 World Bank income levels and gross domestic product, TB health outcome scores (based on amenable mortality), NEML year of publication, total number of TB medicines listed and total TB medicines listed when alternatives and/or equivalent medicines are considered. These data are the basis for our research on essential tuberculosis medicines and health outcomes in countries with a national essential medicines list. All underlying data used were publicly available at a country level, and we make these available for public use with appropriate credit and citation.